Smart Care California

Smart Care California

Smart Care California is a public-private partnership working to promote safe, affordable health care in California. The group currently focuses on three issues: C-sections, opioid overuse and low back pain. Collectively, Smart Care California participants purchase or manage care for more than 16 million Californians—or 40 percent of the state. Smart Care California is co-chaired by the state’s leading health care purchasers: DHCS, which administers Medi-Cal; Covered California, the state’s health insurance marketplace; and CalPERS. IHA convenes and coordinates the partnership with funding from CHCF.
 

 What's New

Reducing Opioid-Related Morbidity and Mortality: Payer and Provider Strategies

Curbing the Opioid Epidemic: Checklist for Health Plans and Purchasers, updated November 2017

Aligning Birth Payment to Reduce Unnecessary C-Section: A Menu of Options

Smart Care California in the News!

Opioid Health Plan Checklist: Health Plan Survey Results
 

Smart Care California Background Information

By some estimates, up to 30 percent of all patient care in the United States is at best ineffective or at worst harmful while increasing costs for everyone. In order to address concerns regarding the increased use of wasteful medical services, Smart Care California, previously known as the Statewide Workgroup on Reducing Overuse, was formed in 2015. Smart Care California engages participants representing physicians, hospitals and health systems, health plans and other payers, purchasers, and consumer organizations to tackle the issue of overuse.

Smart Care California Progress

The dashboard below contains data on select measures from existing sources to highlight statewide progress for Smart Care California’s three focus areas. The dashboard currently includes data from 2015, which serves as baseline, and 2016, as well as the percent relative change between baseline and 2016. This dashboard will be updated on an annual basis.

Measure
Total morphine milligram equivalents (MME) per resident per year
Target
Lower total volume of prescribed opioids by 50% by 2020
Baseline (2015)
544.22
MME per resident
per year
2016
495.65
MME per resident
per year
% Change
 
9.8%
(lower is better)
Measure
Residents on >90MME Daily
(>= 30 days)
per 1000 pts
Target
Lower number of people on high-dose opioids (>90mg MED) by 50% by 2020
Baseline (2015)
24.72
per 1000pts
2016
21.92
per 1000pts
% Change
 
11.3%
(lower is better)
Measure
Residents on Opiods/Benzos
(>= 30 days)
per 1000 pts
Target
Lower number of people receiving both benzodiazepines and opioids by 50% by 2020
Baseline (2015)
20.06
per 1000pts
2016
18.88
per 1000pts
% Change
 
5.9%
(lower is better)
Measure
Number of buprenorphine prescriptions per 1000 residents
Target
Buprenorphine prescriptions quadruple by 2020
Baseline (2015)
12.29
per 1000pts
2016
13.19
per 1000pts
% Change
 
7.3%
(higher is better)
Measure
Nulliparous, Term, Singleton, Vertex (NTSV) C-Secion rate
Target
Statewide average of 23.9% by 2020
Data Source
Baseline (2015)
25.6%
2016
% Change
Measure
Hospitals recognized on the Hospital Honor Roll for acheiving or surpassing the national Healthy People 2020 goal of 23.9% for low-risk first birth C-section
Target
Every hospital that provides maternity care services in California will be recognized on the Hospital Honor Roll by 2020
Baseline (2015)
42.6%
104 out of 244 hospitals
2016
% Change
Measure
Hospitals who are members of the California Maternal Quality Care Collaborative (CMQCC)
Target
Every hospital that provides maternity care services in California will be a CMQCC member by 2020
Baseline (2015)
60.6%
151 out of 249 hospitals1
2016
74.9%
182 out of 243 hospitals1
% Change
 
23.6%
(higher is better)
Measure
In Development
Target
Data Source
Baseline (2015)
2016
% Change
1 CMQCC membership numbers from December of the corresponding year.